Biora Therapeutics, Inc. financial data

Symbol
BIOR on Nasdaq
Industry
Pharmaceutical Preparations
Location
4330 La Jolla Village Drive, Suite 200, San Diego, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
PROGENITY, INC. (to 4/19/2022), ASCENDANT MDX, INC. (to 6/28/2013)
Latest financial report
Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 39 % -75%
Debt-to-equity -131 % +18.6%
Return On Equity 100 % +141%
Return On Assets -320 % -372%
Operating Margin -508 % -161%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30.3 M shares +156%
Common Stock, Shares, Outstanding 30.4 M shares +157%
Entity Public Float 39 M USD -66%
Common Stock, Value, Issued 28 K USD +155%
Weighted Average Number of Shares Outstanding, Basic 29.3 M shares +167%
Weighted Average Number of Shares Outstanding, Diluted 29.3 M shares +167%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 12.2 M USD -79.9%
Revenue from Contract with Customer, Excluding Assessed Tax 544 K USD +172%
Research and Development Expense 29.7 M USD +20.1%
Selling and Marketing Expense -1.74 M USD -115%
Operating Income (Loss) -67.1 M USD -16.9%
Nonoperating Income (Expense) -65.2 M USD -2047%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -111 M USD +76.3%
Income Tax Expense (Benefit) -42 K USD
Net Income (Loss) Attributable to Parent -111 M USD -165%
Earnings Per Share, Basic -6.42 USD/shares -37.8%
Earnings Per Share, Diluted -6.42 USD/shares -37.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.6 M USD -65.2%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Other Assets, Current 169 K USD -45.3%
Assets, Current 14.1 M USD -62.1%
Property, Plant and Equipment, Net 1.14 M USD -24.2%
Operating Lease, Right-of-Use Asset 1.42 M USD -36.9%
Goodwill 6.07 M USD 0%
Other Assets, Noncurrent 293 K USD -95.3%
Assets 23 M USD -56.8%
Accounts Payable, Current 4.94 M USD +44.2%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 51.1 M USD +104%
Operating Lease, Liability, Noncurrent 583 K USD -56.2%
Other Liabilities, Noncurrent 2.58 M USD -48.1%
Liabilities 123 M USD -22.2%
Retained Earnings (Accumulated Deficit) -955 M USD -13.1%
Stockholders' Equity Attributable to Parent -100 M USD +4.58%
Liabilities and Equity 23 M USD -56.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.5 M USD -3.29%
Net Cash Provided by (Used in) Financing Activities 5.1 M USD -57.8%
Net Cash Provided by (Used in) Investing Activities 3.01 M USD
Common Stock, Shares Authorized 164 M shares 0%
Common Stock, Shares, Issued 31.2 M shares +158%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.39 M USD -18991%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 10.8 M USD -64.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 78 K USD
Deferred Tax Assets, Valuation Allowance 149 M USD +5.31%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0 pure
Deferred Tax Assets, Gross 151 M USD +3.58%
Operating Lease, Liability 1.5 M USD -32.3%
Depreciation 600 K USD -33.3%
Payments to Acquire Property, Plant, and Equipment 15 K USD -6.25%
Property, Plant and Equipment, Gross 3.32 M USD -12.4%
Operating Lease, Liability, Current 920 K USD +3.37%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Deferred Income Tax Expense (Benefit) -75 K USD -122%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 140 K USD -51.2%
Deferred Tax Assets, Operating Loss Carryforwards 140 M USD +1.89%
Deferred Federal Income Tax Expense (Benefit) -75 K USD -122%
Current Income Tax Expense (Benefit) -15 K USD +98%
Preferred Stock, Shares Authorized 10 M shares 0%
Operating Lease, Payments 300 K USD -25%
Current State and Local Tax Expense (Benefit) -15 K USD +95.7%
Current Federal Tax Expense (Benefit) 0 USD
Operating Leases, Future Minimum Payments, Due in Two Years 590 K USD -37.1%
Amortization of Intangible Assets 100 K USD -85.7%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 1.02 M USD +5.91%
Share-based Payment Arrangement, Expense 15.6 M USD +92.1%
Operating Leases, Future Minimum Payments, Due in Three Years 264 K USD -47.9%
Operating Leases, Future Minimum Payments Due 1.64 M USD -34.5%
Deferred State and Local Income Tax Expense (Benefit) 0 USD
Interest Expense 9.89 M USD -9.33%